Of 226 PCa patients with higher PSA levels (>10 ng/mL), 138 (61.1%) were PD-L1 expression positive and 338 (58.7%) of 576 PCa patients with lower PSA levels (≤10 ng/mL) were PD-L1 expression positive. This evidence concerns the gene KLK3 and posterior cortical atrophy.